Quinn William P. — SEC Form 4 filings
SEC reporting owner CIK 1724190. 7 Form 4 filings on record with FilingPulse; latest filed 2026-09-21.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-03-06 to 2026-09-21. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 5 legs across 4 filings — 5,887 shares, $6,566 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 3 legs across 1 filing — 17,566 shares, $58,402 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: sale of 9,132 shares @ $3.24 ($29,555) in Bolt Biotherapeutics, Inc., filed 2026-09-21.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | President, CEO and CFO, Director | 7 | 5 legs · 5,887 sh · $6,566 | 3 legs · 17,566 sh · $58,402 | 21 |
Form 4 filings — Quinn William P.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-21 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Purchase (P): 637 @ $3.88 · Sale (S): 1,889 @ $3.77 · Sale (S): 6,545 @ $3.32 · Sale (S): 9,132 @ $3.24 | EDGAR |
| 2026-02-04 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Purchase (P): 125 @ $4.61 · Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2025-12-16 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Grant/award (A): 7,614 (derivative) · Disposition to issuer (D): 7,614 (derivative) · Grant/award (A): 3,927 (derivative) · Disposition to issuer (D): 3,927 (derivative) · Grant/award (A): 5,000 (derivative) · Disposition to issuer (D): 5,000 (derivative) · +10 more | EDGAR |
| 2025-10-24 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Purchase (P): 125 @ $5.49 · Grant/award (A): 40,000 @ $0 | EDGAR |
| 2025-05-05 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Purchase (P): 2,500 @ $0.50 · Purchase (P): 2,500 @ $0.64 · Grant/award (A): 700,000 (derivative) @ $0 | EDGAR |
| 2024-07-24 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Grant/award (A): 440,000 (derivative) @ $0 | EDGAR |
| 2024-03-06 | 4 | Bolt Biotherapeutics, Inc. (BOLT) | Grant/award (A): 235,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-02 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1724190 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →